Transglutaminase 2 interacts with syndecan-4 and CD44 at the surface of human macrophages to promote removal of apoptotic cells

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1853, Issue 1, 2015, Pages 201-212

  Nadella, Vinod ^a   Wang, Zhuo ^a   Johnson, Timothy S ^b   Griffin, Martin ^a   Devitt, Andrew ^a  

^a ASTON UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Apoptotic cell clearance; CD44; Heparan sulphate proteoglycan; Macrophages; Syndecan 4; Transglutaminase 2

Indexed keywords

HERMES ANTIGEN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; PROTEOHEPARAN SULFATE; SYNDECAN 4; CD44 PROTEIN, HUMAN; GUANINE NUCLEOTIDE BINDING PROTEIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

APOPTOSIS; APOPTOTIC CELL CLEARANCE; ARTICLE; CELL ADHESION; CELL MIGRATION; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MACROPHAGE; PHAGOCYTE; PROTEIN CROSS LINKING; PROTEIN PROTEIN INTERACTION; WESTERN BLOTTING; CELL COMMUNICATION; CELL CULTURE; CELL MOTION; PHYSIOLOGY;

ANTIGENS, CD44; APOPTOSIS; CELL COMMUNICATION; CELL MOVEMENT; CELLS, CULTURED; GTP-BINDING PROTEINS; HUMANS; MACROPHAGES; SYNDECAN-4; TRANSGLUTAMINASES;

EID: 84909606142     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2014.09.020     Document Type: Article

References (53)

1. Griffin M., Casadio R., Bergamini C.M. Transglutaminases: nature's biological glues. Biochem. J. 2002, 368(Pt 2):377-396.
2. Thomazy V., Fesus L. Differential expression of tissue transglutaminase in human cells. An immunohistochemical study. Cell Tissue Res. 1989, 255(1):215-224.
3. Verderio E., Nicholas B., Gross S., Griffin M. Regulated expression of tissue transglutaminase in Swiss 3T3 fibroblasts: effects on the processing of fibronectin, cell attachment, and cell death. Exp. Cell Res. 1998, 239(1):119-138.
4. Akimov S.S., Krylov D., Fleischman L.F., Belkin A.M. Tissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectin. J. Cell Biol. 2000, 148(4):825-838.
5. Scarpellini A., Germack R., Lortat-Jacob H., Muramatsu T., Billett E., Johnson T., et al. Heparan sulfate proteoglycans are receptors for the cell-surface trafficking and biological activity of transglutaminase-2. J. Biol. Chem. 2009, 284(27):18411-18423.
6. Wang Z., Collighan R.J., Gross S.R., Danen E.H., Orend G., Telci D., et al. RGD-independent cell adhesion via a tissue transglutaminase-fibronectin matrix promotes fibronectin fibril deposition and requires syndecan-4/2 and {alpha}5{beta}1 integrin co-signaling. J. Biol. Chem. 2010, 285(51):40212-40229.
7. Wang Z., Telci D., Griffin M. Importance of syndecan-4 and syndecan-2 in osteoblast cell adhesion and survival mediated by a tissue transglutaminase-fibronectin complex. Exp. Cell Res. 2011, 317(3):367-381.
8. Wang Z., Collighan R.J., Pytel K., Rathbone D.L., Li X., Griffin M. Characterization of heparin-binding site of tissue transglutaminase: its importance in cell surface targeting, matrix deposition, and cell signaling. J. Biol. Chem. 2012, 287(16):13063-13083.
9. Lorand L., Graham R.M. Transglutaminases: crosslinking enzymes with pleiotropic functions. Nat. Rev. Mol. Cell Biol. 2003, 4(2):140-156.
10. Telci D., Wang Z., Li X., Verderio E.A., Humphries M.J., Baccarini M., et al. Fibronectin-tissue transglutaminase matrix rescues RGD-impaired cell adhesion through syndecan-4 and beta1 integrin co-signaling. J. Biol. Chem. 2008, 283(30):20937-20947.
11. Wang Z., Griffin M. TG2, a novel extracellular protein with multiple functions. Amino Acids 2012, 42(2-3):939-949.
12. Wang Z., Griffin M. The role of TG2 in regulating S100A4-mediated mammary tumour cell migration. PLoS One 2013, 8(3):e57017.
13. Savill J., Dransfield I., Gregory C., Haslett C. A blast from the past: clearance of apoptotic cells regulates immune responses. Nat. Rev. Immunol. 2002, 2(12):965-975.
14. Grimsley C., Ravichandran K.S. Cues for apoptotic cell engulfment: eat-me, don't eat-me and come-get-me signals. Trends Cell Biol. 2003, 13(12):648-656.
15. Gregory C.D., Devitt A. The macrophage and the apoptotic cell: an innate immune interaction viewed simplistically?. Immunology 2004, 113(1):1-14.
16. Devitt A., Marshall L.J. The innate immune system and the clearance of apoptotic cells. J. Leukoc. Biol. 2011, 90(3):447-457.
17. Hochreiter-Hufford A., Ravichandran K.S. Clearing the dead: apoptotic cell sensing, recognition, engulfment, and digestion. Cold Spring Harb. Perspect. Biol. 2013, 5(1):a008748.
18. -/- mice reveal a phagocytosis-associated crosstalk between macrophages and apoptotic cells. Proc. Natl. Acad. Sci. U. S. A. 2003, 100(13):7812-7817.
19. Toth B., Garabuczi E., Sarang Z., Vereb G., Vamosi G., Aeschlimann D., et al. Transglutaminase 2 is needed for the formation of an efficient phagocyte portal in macrophages engulfing apoptotic cells. J. Immunol. 2009, 182(4):2084-2092.
20. Hart S.P., Rossi A.G., Haslett C., Dransfield I. Characterization of the effects of cross-linking of macrophage CD44 associated with increased phagocytosis of apoptotic PMN. PLoS One 2012, 7(3):e33142.
21. Freund K.F., Doshi K.P., Gaul S.L., Claremon D.A., Remy D.C., Baldwin J.J., et al. Transglutaminase inhibition by 2-[(2-oxopropyl)thio]imidazolium derivatives: mechanism of factor XIIIa inactivation. Biochemistry 1994, 33(33):10109-10119.
22. Griffin M., Mongeot A., Collighan R., Saint R.E., Jones R.A., Coutts I.G., et al. Synthesis of potent water-soluble tissue transglutaminase inhibitors. Bioorg. Med. Chem. Lett. 2008, 18(20):5559-5562.
23. Baumgartner W., Golenhofen N., Weth A., Hiiragi T., Saint R., Griffin M., et al. Role of transglutaminase 1 in stabilisation of intercellular junctions of the vascular endothelium. Histochem. Cell Biol. 2004, 122(1):17-25.
24. Badarau E., Collighan R.J., Griffin M. Recent advances in the development of tissue transglutaminase (TG2) inhibitors. Amino Acids 2013, 44(1):119-127.
25. Gregory C.D., Dive C., Henderson S., Smith C.A., Williams G.T., Gordon J., et al. Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Nature 1991, 349(6310):612-614.
26. Haslett C., Guthrie L.A., Kopaniak M.M., Johnston R.B., Henson P.M. Modulation of multiple neutrophil functions by preparative methods or trace concentrations of bacterial lipopolysaccharide. Am. J. Pathol. 1985, 119(1):101-110.
27. Devitt A., Moffatt O.D., Raykundalia C., Capra J.D., Simmons D.L., Gregory C.D. Human CD14 mediates recognition and phagocytosis of apoptotic cells. Nature 1998, 392(6675):505-509.
28. Thomas L., Bielemeier A., Lambert P.A., Darveau R.P., Marshall L.J., Devitt A. The N-terminus of CD14 acts to bind apoptotic cells and confers rapid-tethering capabilities on non-myeloid cells. PLoS One 2013, 8(7):e70691.
29. Torr E.E., Gardner D.H., Thomas L., Goodall D.M., Bielemeier A., Willetts R., et al. Apoptotic cell-derived ICAM-3 promotes both macrophage chemoattraction to and tethering of apoptotic cells. Cell Death Differ. 2012, 19(4):671-679.
30. -/- mice. J. Cell Biol. 2004, 167(6):1161-1170.
31. Chaubey S., Ridley A.J., Wells C.M. Using the Dunn chemotaxis chamber to analyze primary cell migration in real time. Methods Mol. Biol. 2011, 769:41-51.
32. Siegel M., Khosla C. Transglutaminase 2 inhibitors and their therapeutic role in disease states. Pharmacol. Ther. 2007, 115(2):232-245.
33. Wang Z., Perez M., Caja S., Melino G., Johnson T.S., Lindfors K., et al. A novel extracellular role for tissue transglutaminase in matrix-bound VEGF-mediated angiogenesis. Cell Death Dis. 2013, 4:e808.
34. Fadok V.A., Bratton D.L., Konowal A., Freed P.W., Westcott J.Y., Henson P.M. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J. Clin. Invest. 1998, 101(4):890-898.
35. Pure E., Cuff C.A. A crucial role for CD44 in inflammation. Trends Mol. Med. 2001, 7(5):213-221.
36. Ponta H., Sherman L., Herrlich P.A. CD44: from adhesion molecules to signalling regulators. Nat. Rev. Mol. Cell Biol. 2003, 4(1):33-45.
37. Screaton G.R., Bell M.V., Jackson D.G., Cornelis F.B., Gerth U., Bell J.I. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc. Natl. Acad. Sci. U. S. A. 1992, 89(24):12160-12164.
38. Vachon E., Martin R., Plumb J., Kwok V., Vandivier R.W., Glogauer M., et al. CD44 is a phagocytic receptor. Blood 2006, 107(10):4149-4158.
39. Hodrea J., Demeny M.A., Majai G., Sarang Z., Korponay-Szabo I.R., Fesus L. Transglutaminase 2 is expressed and active on the surface of human monocyte-derived dendritic cells and macrophages. Immunol. Lett. 2010, 130(1-2):74-81.
40. Akimov S.S., Belkin A.M. Cell surface tissue transglutaminase is involved in adhesion and migration of monocytic cells on fibronectin. Blood 2001, 98(5):1567-1576.
41. Thomas-Ecker S., Lindecke A., Hatzmann W., Kaltschmidt C., Zanker K.S., Dittmar T. Alteration in the gene expression pattern of primary monocytes after adhesion to endothelial cells. Proc. Natl. Acad. Sci. U. S. A. 2007, 104(13):5539-5544.
42. Seiving B., Ohlsson K., Linder C., Stenberg P. Transglutaminase differentiation during maturation of human blood monocytes to macrophages. Eur. J. Haematol. 1991, 46(5):263-271.
43. van Strien M.E., Breve J.J., Fratantoni S., Schreurs M.W., Bol J.G., Jongenelen C.A., et al. Astrocyte-derived tissue transglutaminase interacts with fibronectin: a role in astrocyte adhesion and migration?. PLoS One 2011, 6(9):e25037.
44. Bass M.D., Roach K.A., Morgan M.R., Mostafavi-Pour Z., Schoen T., Muramatsu T., et al. Syndecan-4-dependent Rac1 regulation determines directional migration in response to the extracellular matrix. J. Cell Biol. 2007, 177(3):527-538.
45. Guazzone V.A., Denduchis B., Lustig L. Involvement of CD44 in leukocyte recruitment to the rat testis in experimental autoimmune orchitis. Reproduction 2005, 129(5):603-609.
46. Teder P., Vandivier R.W., Jiang D., Liang J., Cohn L., Pure E., et al. Resolution of lung inflammation by CD44. Science 2002, 296(5565):155-158.
47. Levesque M.C., Haynes B.F. TNFalpha and IL-4 regulation of hyaluronan binding to monocyte CD44 involves posttranslational modification of CD44. Cell. Immunol. 1999, 193(2):209-218.
48. Naor D., Sionov R.V., Ish-Shalom D. CD44: structure, function, and association with the malignant process. Adv. Cancer Res. 1997, 71:241-319.
49. Underhill C. CD44: the hyaluronan receptor. J. Cell Sci. 1992, 103(Pt 2):293-298.
50. Mackay C.R., Terpe H.J., Stauder R., Marston W.L., Stark H., Gunthert U. Expression and modulation of CD44 variant isoforms in humans. J. Cell Biol. 1994, 124(1-2):71-82.
51. Hart S.P., Dougherty G.J., Haslett C., Dransfield I. CD44 regulates phagocytosis of apoptotic neutrophil granulocytes, but not apoptotic lymphocytes, by human macrophages. J. Immunol. 1997, 159(2):919-925.
52. Cuff C.A., Kothapalli D., Azonobi I., Chun S., Zhang Y., Belkin R., et al. The adhesion receptor CD44 promotes atherosclerosis by mediating inflammatory cell recruitment and vascular cell activation. J. Clin. Investig. 2001, 108(7):1031-1040.
53. Stoop R., Gal I., Glant T.T., McNeish J.D., Mikecz K. Trafficking of CD44-deficient murine lymphocytes under normal and inflammatory conditions. Eur. J. Immunol. 2002, 32(9):2532-2542.